AR026708A1 - Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma - Google Patents

Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma

Info

Publication number
AR026708A1
AR026708A1 ARP000106395A ARP000106395A AR026708A1 AR 026708 A1 AR026708 A1 AR 026708A1 AR P000106395 A ARP000106395 A AR P000106395A AR P000106395 A ARP000106395 A AR P000106395A AR 026708 A1 AR026708 A1 AR 026708A1
Authority
AR
Argentina
Prior art keywords
indazol
glaucoma
treatment
hydroxy
derivatives
Prior art date
Application number
ARP000106395A
Other languages
English (en)
Spanish (es)
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AR026708A1 publication Critical patent/AR026708A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP000106395A 2000-03-17 2000-12-01 Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma AR026708A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19028300P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
AR026708A1 true AR026708A1 (es) 2003-02-26

Family

ID=22700701

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000106395A AR026708A1 (es) 2000-03-17 2000-12-01 Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma

Country Status (12)

Country Link
EP (1) EP1268439A1 (fr)
JP (1) JP2003535821A (fr)
KR (1) KR20030095183A (fr)
CN (1) CN1450995A (fr)
AR (1) AR026708A1 (fr)
AU (2) AU1918001A (fr)
BR (1) BR0017163A (fr)
CA (1) CA2401959A1 (fr)
MX (1) MXPA02008825A (fr)
PL (1) PL365422A1 (fr)
WO (1) WO2001070701A1 (fr)
ZA (1) ZA200206853B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6960579B1 (en) 1998-05-19 2005-11-01 Alcon Manufacturing, Ltd. Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
JP2004535418A (ja) 2001-06-01 2004-11-25 アルコン，インコーポレイテッド ピラノインダゾールおよび緑内障治療への使用
TW593302B (en) 2001-12-20 2004-06-21 Alcon Inc Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
CN100384827C (zh) * 2002-11-08 2008-04-30 默克公司 用于治疗高眼压症的眼用组合物
JP2006510742A (ja) * 2002-11-08 2006-03-30 メルク　エンド　カムパニー　インコーポレーテッド 高眼圧治療用眼科組成物
US7196082B2 (en) * 2002-11-08 2007-03-27 Merck & Co. Inc. Ophthalmic compositions for treating ocular hypertension
WO2004054572A2 (fr) 2002-12-13 2004-07-01 Alcon, Inc. Nouveaux analogues de benzopyranne et leur utilisation pour le traitement du glaucome
JP2004262812A (ja) * 2003-02-28 2004-09-24 Rohto Pharmaceut Co Ltd 眼圧低下剤
WO2005025568A1 (fr) * 2003-09-04 2005-03-24 Merck & Co., Inc. Compositions ophtalmiques pour traiter l'hypertension oculaire
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
US7129257B1 (en) 2003-12-15 2006-10-31 Alcon, Inc. Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma
AR046890A1 (es) 2003-12-15 2005-12-28 Alcon Inc [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma.
BRPI0518693A2 (pt) 2004-11-29 2008-12-02 Warner Lambert Co pirazol [3,4-b]piridinas e indazàis terapÊuticos, bem como composiÇço farmacÊutica e uso dos mesmos
WO2006062839A1 (fr) 2004-12-08 2006-06-15 Alcon, Inc. Utilisation de dioxindoindazoles et de dioxoloindazoles pour traiter le glaucome
KR100972921B1 (ko) * 2009-12-02 2010-07-28 제이케이이앤씨 주식회사 회전 격판식 선회류 세정 및 탈취장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2680366B1 (fr) * 1991-08-13 1995-01-20 Adir Nouveaux derives d'arylethylamines, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
BR9910590A (pt) * 1998-05-19 2001-01-23 Alcon Lab Inc Composto, processo para diminuir iop, para melhorar o fluxo sanguìneo para a extremidade do nervo óptico e a retina, e para tratar doenças retinais, composições para diminuir iop, para melhorar o fluxo sanguìneo para a extremidade do nervo óptico e a retina, e para tratar doenças retinais, processo e composição para prover neuroproteção para a extremidade do nervo óptico ou a retina, e, processo para tratar pessoas sofrendo de distúrbios do sono, depressão, esquizofrenia, ansiedade, distúrbios rìtmicos circadianos e hipertensão centralmente e perifericamente mediada
GB9819020D0 (en) * 1998-09-01 1998-10-28 Cerebrus Ltd Chemical compounds III
BR9913800A (pt) * 1998-09-18 2001-05-29 Alcon Lab Inc Método para tratar glaucoma, e, composição para tratar glaucoma

Also Published As

Publication number Publication date
ZA200206853B (en) 2004-11-02
KR20030095183A (ko) 2003-12-18
CN1450995A (zh) 2003-10-22
AU2001219180B2 (en) 2005-04-07
WO2001070701A1 (fr) 2001-09-27
BR0017163A (pt) 2003-01-14
PL365422A1 (en) 2005-01-10
JP2003535821A (ja) 2003-12-02
CA2401959A1 (fr) 2001-09-27
EP1268439A1 (fr) 2003-01-02
MXPA02008825A (es) 2004-10-15
AU1918001A (en) 2001-10-03

Similar Documents

Publication Publication Date Title
AR026708A1 (es) Derivados de 5-hidroxi-indazol para el tratamiento de glaucoma
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
ATE340171T1 (de) Piperazinderivate zur behandlung bakterieller infektionen
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
ATE202706T1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
AR020442A1 (es) Agonistas de 5ht2serotonergicos para el tratamiento de glaucoma
EP1507556A4 (fr) Conjugues de type vecteur-derive de calicheamicine
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
BR0215405A (pt) Composições e processos de uso de collajolie
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
ATE233274T1 (de) Oxyiminopregnancarbolactone
DE60331638D1 (de) Keratin-netzwerke enthaltende wundverbände für gewebedefekte
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
ECSP044862A (es) Pirenzepine ophthalmic gel
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
WO1998039293A3 (fr) 13-thia prostaglandines destinees a etre utilisees dans la therapie du glaucome
AR026707A1 (es) Agonistas de 5ht2 para el control de pio y para el tratamiento de glaucoma
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
ATE417856T1 (de) Motilidverbindungen
ES2178765T3 (es) Nuevos derivados de 1,7,7-trimetil-biciclo (2.2.1) heptano.
BR0314419A (pt) Compostos de 5-croman-5-il-etilamina substituìdos, seu uso e composição farmacêutica incluindo-o
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
BR0017168A (pt) Piranoindóis para tratamento de glaucoma

Legal Events

Date Code Title Description
FB Suspension of granting procedure